Profil
Ms. Grith Hagel is a Director & Vice President-Innovation at 2cureX AB and a Head-Project Management at 2cureX ApS.
She is on the Board of Directors at 2cureX AB. Ms. Hagel was previously employed as a Principal by Carlsberg A/S, a Co-Founder by Noapab Holdings A/S, and a Principal by Novo Nordisk A/S.
Aktive Positionen von Grith Hagel
| Unternehmen | Position | Beginn |
|---|---|---|
| 2CUREX AB | Gründer | 01.01.2006 |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer | Gründer | 07.04.2010 |
Ehemalige bekannte Positionen von Grith Hagel
| Unternehmen | Position | Ende |
|---|---|---|
| CARLSBERG A/S | Corporate Officer/Principal | - |
Noapab Holdings A/S
Noapab Holdings A/S Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and diagnostics products | Gründer | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Carlsberg A/S
Carlsberg A/S Beverages: AlcoholicConsumer Non-Durables Produces and markets beers and soft drinks | Consumer Non-Durables |
Noapab Holdings A/S
Noapab Holdings A/S Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and diagnostics products | Commercial Services |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer | Health Technology |
2cureX AB
2cureX AB Medical SpecialtiesHealth Technology Develops and supplies in vitro diagnostic (IVD) devices | Health Technology |
















